Search the Newsreel

GXO Logistics (GXO) Returned To Profitability, Is The Stock Still Undervalued?

GXO Logistics (GXO) has returned to profitability in the first half of 2026 with sales of US$3,441 million for the quarter. While the stock has seen declining long-term shareholder returns, its share price has recently shown a modest 3.05% return over 90 days. The …

23,257 Shares in Corcept Therapeutics Incorporated $CORT Purchased by GSA Capital Partners LLP

GSA Capital Partners LLP recently acquired a new position of 23,257 shares in Corcept Therapeutics Incorporated (NASDAQ:CORT) during the second quarter, valued at approximately $2.022 million. Other institutional investors have also adjusted their holdings in CORT, with 93.61% of the stock owned by hedge …

Focus Partners Advisor Solutions LLC Makes New $6.70 Million Investment in General Dynamics Corporation $GD

Focus Partners Advisor Solutions LLC has invested $6.70 million in General Dynamics Corporation by acquiring 18,907 shares. This comes amidst other institutional investors modifying their holdings and various analysts issuing reports with target price adjustments and ratings for General Dynamics, which recently reported strong …

Bank of America Corp DE Purchases 240,902 Shares of PennyMac Financial Services, Inc. $PFSI

Bank of America Corp DE significantly increased its stake in PennyMac Financial Services (NYSE:PFSI) by 173.9% in the first quarter, acquiring an additional 240,902 shares. This brings their total holding to 379,429 shares, valued at approximately $33.2 million. Despite PennyMac missing its Q1 EPS …

ABN AMRO Bank N.V. Takes $21.52 Million Position in Quest Diagnostics Incorporated $DGX

ABN AMRO Bank N.V. recently acquired a new position in Quest Diagnostics Incorporated, purchasing 101,667 shares valued at approximately $21.52 million during the second quarter. This investment makes ABN AMRO Bank N.V. an approximate 0.09% owner of the medical research company. Other institutional investors …

Mineralys Therapeutics, Inc. $MLYS Shares Bought by Bank of America Corp DE

TransMedics Group, Inc. (NASDAQ:TMDX) Receives Average Recommendation of "Hold" from Brokerages

TransMedics Group, Inc. (NASDAQ:TMDX) has received a consensus "Hold" rating from brokerages, with six analysts recommending "buy," six "hold," and one "sell." The average 12-month price target for the stock is $124.18. The company recently reported quarterly revenue of $189.95 million, exceeding estimates, but …

Daiwa House Logistics Trust - Lower DPU due to higher interest cost and weaker JPY

Astronics (NASDAQ:ATRO) Rating Increased to Strong-Buy at Wall Street Zen

Wall Street Zen has upgraded Astronics (NASDAQ:ATRO) to a "strong-buy" rating, while the broader analyst consensus remains "Buy" with an average price target of $74.17. The aerospace company recently reported strong quarterly results, with EPS of $0.70, beating estimates, and revenue of $259.96 million, …

Wall Street Zen Upgrades Avalo Therapeutics (NASDAQ:AVTX) to Hold

Wall Street Zen has upgraded Avalo Therapeutics (NASDAQ:AVTX) from a "sell" to a "hold" rating, though the consensus among other analysts remains a "Moderate Buy" with an average price target of $45.10. The company reported a quarterly loss of $0.83 per share, missing estimates. …

Cytokinetics (NASDAQ:CYTK) Raised to Hold at Wall Street Zen

Wall Street Zen upgraded Cytokinetics (NASDAQ:CYTK) from "Sell" to "Hold" on Sunday, despite the broader analyst consensus remaining a "Moderate Buy." The company exceeded quarterly expectations with an adjusted loss of $1.50 per share and revenue of $28.62 million. While company insiders sold shares, …

Atara Biotherapeutics (NASDAQ:ATRA) Rating Increased to Hold at Wall Street Zen

Wall Street Zen has upgraded Atara Biotherapeutics (NASDAQ:ATRA) from "Sell" to "Hold," reflecting an average "Hold" consensus among analysts with an average price target of $9.50. Despite the upgrade, ATRA shares opened down 4.9% at $8.09, with the company reporting a quarterly loss of …

Wall Street Zen Upgrades Home BancShares (NYSE:HOMB) to Hold

Wall Street Zen has upgraded Home BancShares (NYSE:HOMB) from a "sell" to a "hold" rating, aligning with the overall analyst sentiment of "Hold." The company recently reported strong quarterly earnings, exceeding estimates with an EPS of $0.64 and revenue of $295.1 million, an 8.9% …

MacroGenics (MGNX) Stock Faces A Revenue Reality Check After Deeper Losses

Results: LG Electronics India Limited Exceeded Expectations And The Consensus Has Updated Its Estimates

Should I buy Scribe Therapeutics Inc. (SCTX)

Why AbCellera (ABCL) Is Up 64.2% After Menopause Trial Win, Equity Raise And Vertex Deal

AbCellera Biologics (ABCL) saw its stock rise by 64.2% following positive Phase 2 results for its menopause drug ABCL635, a US$200 million equity raise, and a new collaboration with Vertex Pharmaceuticals. These developments strengthen its clinical pipeline and funding base, with the Vertex deal …

Price-Driven Insight from (ZVRA) for Rule-Based Strategy

This article provides a price-driven analysis for Zevra Therapeutics Inc. (NASDAQ: ZVRA), highlighting weak near-term sentiment but strong mid and long-term outlooks. It details institutional trading strategies including position, momentum breakout, and risk hedging, along with multi-timeframe signal analysis, and an exceptional risk-reward short …

Arcutis (ARQT) Q2 2026 Earnings Call Transcript

Nektar Therapeutics (NKTR) Stock Slides As Cash Burn Clouds Pipeline Progress

Nektar Therapeutics' stock fell 4% following its Q2 2026 earnings report, despite progress in its autoimmune pipeline, notably rezpegaldesleukin. The market reacted negatively to the company's substantial cash burn, with a quarterly net loss exceeding US$40 million and trailing 12-month losses widening. While the …

Quantinno Capital Management LP Purchases 169,477 Shares of Grid Dynamics Holdings, Inc. $GDYN

Quantinno Capital Management LP significantly increased its stake in Grid Dynamics Holdings, Inc. by 460.4% in the first quarter, acquiring 169,477 additional shares. This brings their total holdings to 206,289 shares valued at approximately $1.18 million. Despite some insider selling, institutional investors collectively own …

Haemonetics (HAE) Stock Could Be 49% Below Fair Value On Raised Guidance

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Haemonetics stock has delivered a strong 69.0% return over the past year, yet the valuation signals are mixed, with an intrinsic value estimate …

Haemonetics (HAE) Earnings Beat Puts Fair Value Back In Focus

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Haemonetics (HAE) has drawn fresh attention after reporting first quarter fiscal 2027 results, with sales of US$339.38 million and net income of US$33.01 …

AbCellera (ABCL) Soars 64% as Drug Candidate Holds Huge Market Opportunity

AbCellera (ABCL) saw its stock price jump by 64% last week, becoming the top-performing mid-cap stock in the US market, following strong phase 2 clinical trial results for its drug candidate ABCL635 for hot flashes in menopausal women. The drug successfully reduced hot flash …

The Army gave General Dynamics $533M to build an artillery plant that produced nothing

The U.S. Army spent $533 million on a General Dynamics artillery plant in Mesquite, Texas, intended to produce shells for Ukraine, but the facility never yielded a single usable shell. Despite promises of innovative Turkish-made robots, the plant was plagued by repeated failures, including …

How Rapport Therapeutics Inc. (RAPP) Affects Rotational Strategy Timing

This article analyzes Rapport Therapeutics Inc. (RAPP) using AI models to determine its effect on rotational strategy timing. Key findings suggest a strong sentiment supporting an overweight bias, with resistance being tested. The analysis provides specific institutional trading strategies, including position trading, momentum breakout, …

Understanding Momentum Shifts in (PACS)

This article analyzes momentum shifts for Pacs Group Inc. (NASDAQ: PACS), highlighting weak near-term sentiment but long-term strength. It details institutional trading strategies, including long, breakout, and short positions, along with multi-timeframe signal analysis to guide investors on support and resistance levels.

Vivos Therapeutics, Inc. (VVOS) Reports Q2 Loss, Lags Revenue Estimates

Vivos Therapeutics, Inc. (VVOS) reported a Q2 loss of $0.31 per share, which was better than the Zacks Consensus Estimate of a $0.42 loss. However, the company missed revenue estimates, posting $5.15 million against an expected $5.43 million. Despite beating EPS estimates two out …

How TG Therapeutics’ Q2 2026 Revenue Surge And Higher Guidance At TG Therapeutics (TGTX) Has Changed Its Investment Story

FCBC|First Community Bankshares Inc|Price:49.520|Chg%:+0.200

Zevra Therapeutics (ZVRA) insider files to resell RSU shares via broker

An insider at Zevra Therapeutics (ZVRA) has filed a Form 144 notice to resell up to 42,666 common shares. These shares are linked to restricted stock units granted in June 2025 and are planned for potential sale on NASDAQ. The filing also references previous …

Home Bancshares director Jim Rankin sells $462,966 in HOMB stock

Jim Rankin, a director at Home Bancshares Inc. (NASDAQ:HOMB), sold 15,000 shares of company stock worth $462,966 on August 11, 2026. Following the sale, Rankin still holds over 209,000 shares of common stock and 6,000 restricted shares. This comes after Home Bancshares reported strong …

Sarepta Stock Dips After Hours: DMD Drug Blow And CEO Exit Eclipse Q4 Revenue Beat

ALGS Stock Rallies 16% After-Hours On $25M Cash Boost From China Hepatitis B Drug Deal

What date does Scribe Therapeutics Inc.'s (SCTX) report Earnings - Earnings Calendar & Announcement

TRAX Price Today: First Tracks Biotherapeutics, Inc. Stock Price, Quote & Chart | MEXC

This article provides current stock price information for First Tracks Biotherapeutics, Inc. (TRAX) on MEXC, detailing its live price, market data, and recent performance. It also includes instructions on how to buy TRAX on MEXC and offers a company overview, including its focus on …